1. Home
  2. MIND vs GANX Comparison

MIND vs GANX Comparison

Compare MIND & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIND
  • GANX
  • Stock Information
  • Founded
  • MIND 1987
  • GANX 2017
  • Country
  • MIND United States
  • GANX United States
  • Employees
  • MIND N/A
  • GANX N/A
  • Industry
  • MIND Industrial Machinery/Components
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIND Industrials
  • GANX Health Care
  • Exchange
  • MIND Nasdaq
  • GANX Nasdaq
  • Market Cap
  • MIND 49.6M
  • GANX 51.8M
  • IPO Year
  • MIND 1994
  • GANX 2021
  • Fundamental
  • Price
  • MIND $9.45
  • GANX $1.46
  • Analyst Decision
  • MIND
  • GANX Strong Buy
  • Analyst Count
  • MIND 0
  • GANX 5
  • Target Price
  • MIND N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • MIND 200.8K
  • GANX 271.1K
  • Earning Date
  • MIND 09-10-2025
  • GANX 08-11-2025
  • Dividend Yield
  • MIND N/A
  • GANX N/A
  • EPS Growth
  • MIND N/A
  • GANX N/A
  • EPS
  • MIND 2.91
  • GANX N/A
  • Revenue
  • MIND $45,087,000.00
  • GANX N/A
  • Revenue This Year
  • MIND $7.27
  • GANX N/A
  • Revenue Next Year
  • MIND N/A
  • GANX N/A
  • P/E Ratio
  • MIND $3.31
  • GANX N/A
  • Revenue Growth
  • MIND 26.68
  • GANX N/A
  • 52 Week Low
  • MIND $3.05
  • GANX $0.89
  • 52 Week High
  • MIND $11.10
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • MIND 66.90
  • GANX 35.82
  • Support Level
  • MIND $7.12
  • GANX $1.55
  • Resistance Level
  • MIND $10.12
  • GANX $1.72
  • Average True Range (ATR)
  • MIND 0.49
  • GANX 0.12
  • MACD
  • MIND 0.19
  • GANX -0.01
  • Stochastic Oscillator
  • MIND 77.89
  • GANX 5.94

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: